A Comprehensive Evaluation of miR-144-3p Expression and Its Targets in Laryngeal Squamous Cell Carcinoma

Figure 1

The expression of miR-144-3p and its clinical significance in LSCC and non-LSCC samples. (a) The expression differences of miR-144-3p in each study; (b) the pooled level of miR-144-3p in LSCC evaluated by random effects model; (c) Begg’s test for the publication bias of included studies; (d) ROC curves indicating the potential ability of miR-144-3p in distinguishing LSCC from non-LSCC samples based on each study; (e) and summarized ROC curve indicating the potential ability of miR-144-3p in distinguishing LSCC from non-LSCC samples by integrating four studies.

(a)

(b)

(c)

(d)

(e)